New study decodes how tumor “stress droplets” fuel resistance—and how to shut them down
Peer-Reviewed Publication
Updates every hour. Last Updated: 9-Nov-2025 14:10 ET (9-Nov-2025 19:10 GMT/UTC)
A Science China Life Sciences study reveals that glioblastoma (GBM) hijacks oxygen-deprived conditions by forming nuclear “stress droplets” that activate the enzyme PRMT2, fueling tumor survival independently of the classic HIF pathway. Blocking PRMT2’s phosphorylation with the orphan drug TG02 dismantles these droplets and—when combined with standard chemotherapy temozolomide—restores drug sensitivity, dramatically shrinking tumors and extending survival in resistant mouse models.
A study published today in Nature Communications describes how lymphatic endothelial cells assist in generating robust immune memory, offering new insights into how the immune system functions.
Specifically, the researchers found there is a particular genetic program within the lymphatic endothelial cells that enables storage and archival of portions of an immunization or pathogen (antigens) for future use.
The research is among the first to outline that there’s a genetic “transcriptional” program within lymphatic endothelial cells that impact the immune response and could be manipulated.
The study was led by researchers from the University of Colorado Anschutz, with experts in medicine, immunology and microbiology and biochemistry and molecular genetics.
World's first successful development of innovative nanocomposites comprising lactic acid bacteria components and liquid metal
Selective tumor accumulation via EPR effect with demonstrated visualization and therapeutic efficacy in mouse-transplanted cancers
Complete cancer elimination through synergistic immune activation and photothermal conversion effects under near-infrared light irradiation
Confirmed excellent biocompatibility, promising new cancer diagnostic and therapeutic technologiesUC Irvine researchers explore a new treatment for reversing or possibly preventing age-related vision loss, and the findings could extend to boosting immune system health and fighting cancer.
Women who miss their first mammogram run a higher risk of being diagnosed with advanced breast cancer and dying from the disease. This is shown in a new study from Karolinska Institutet published in the scientific journal BMJ.
Researchers at Duke University have shown that blocking an enzyme involved in iron regulation not only kills multiple myeloma cancer cells, but also increases the effectiveness of current therapies against the disease.